| Literature DB >> 28824667 |
Zhiyuan Liu1,2, Jianli Liang1, Shuning Zheng1, Jifang Zhang1, Jian Wu1, Feng Cheng1, Wencai Yang2, Xiaowu Wang1.
Abstract
Sulforaphane, the hydrolytic product of glucoraphanin glucosinolate, is a potent anticarcinogen that reduces the risk of several human cancers. However, in most B. rapa vegetables, glucoraphanin is undetectable or only present in trace amounts, since the glucoraphanin that is present is converted to gluconapin by three functional BrAOP2 genes. In this study, to enrich beneficial glucoraphanin content in B. rapa, the functional BrAOP2 alleles were replaced by non-functional counterparts through marker-assisted backcrossing (MAB). We identified non-functional mutations of two BrAOP2 genes from B. rapa. The backcross progenies with introgression of both non-functional braop2.2 and braop2.3 alleles significantly increased the glucoraphanin content by 18 times relative to the recurrent parent. In contrast, replacement or introgression of single non-functional braop2.2 or braop2.3 locus did not change glucoraphanin content. Our results suggest that replacement of these two functional BrAOP2 genes with non-functional alleles has the potential for producing improved Brassica crops with enriched beneficial glucoraphanin content.Entities:
Keywords: BrAOP2; Brassica rapa; Marker-assisted backcrossing; glucoraphanin; glucosinolate
Year: 2017 PMID: 28824667 PMCID: PMC5539120 DOI: 10.3389/fpls.2017.01329
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Glucosinolates in leaves of B. rapa (μmol g−1 DW).
| Chinese cabbage | 1.21 ± 0.77 | 0.91 ± 1.51 | 1.16 ± 1.45 | nd | 3.28 ± 2.91 | 0.98 ± 0.61 | 0.37 ± 0.19 | 0.30 ± 0.28 | 0.11 ± 0.10 | 1.76 ± 0.71 |
| Caixin | 1.02 ± 1.53 | 5.64 ± 5.20 | 0.74 ± 0.40 | nd | 7.39 ± 6.84 | 0.25 ± 0.13 | 0.12 ± 0.05 | 0.18 ± 0.16 | 0.05 ± 0.03 | 0.61 ± 0.32 |
| Komatsuna | 0.60 ± 0.07 | 10.20 ± 0.20 | 4.53 ± 5.28 | nd | 15.33 ± 5.55 | 0.39 ± 0.26 | 0.11 ± 0.01 | 0.31 ± 0.17 | 0.07 ± 0.04 | 0.88 ± 0.47 |
| Pakchoi | 0.85 ± 0.20 | 2.63 ± 2.33 | 0.87 ± 1.14 | nd | 4.35 ± 2.97 | 0.28 ± 0.12 | 0.14 ± 0.08 | 0.20 ± 0.11 | 0.08 ± 0.08 | 0.70 ± 0.20 |
| Mizuna | 0.37 ± 0.04 | 18.50 ± 8.00 | 1.19 ± 0.11 | nd | 20.06 ± 8.27 | 0.39 ± 0.12 | 0.17 ± 0.09 | 0.29 ± 0.18 | 0.08 ± 0.03 | 0.92 ± 0.42 |
| Taicai | 1.63 ± 0.79 | 3.11 ± 1.29 | 3.64 ± 1.43 | nd | 8.38 ± 3.05 | 0.48 ± 0.27 | 0.10 ± 0.03 | 0.56 ± 0.32 | 0.19 ± 0.09 | 1.32 ± 0.50 |
| Turnip | 0.44 ± 0.25 | 24.58 ± 10.70 | 7.49 ± 3.73 | nd | 32.51 ± 13.38 | 0.46 ± 0.06 | 0.15 ± 0.12 | 0.30 ± 0.07 | 0.13 ± 0.03 | 1.04 ± 0.10 |
| Wutacai | 0.71 ± 0.07 | 2.35 ± 2.78 | 2.02 ± 2.52 | nd | 5.09 ± 5.37 | 0.71 ± 0.01 | 0.10 ± 0.01 | 1.01 ± 1.07 | 0.07 ± 0.02 | 1.90 ± 1.06 |
| Yellow sarson | 0.60 ± 0.09 | 22.96 ± 0.35 | 0.22 ± 0.15 | 2.87 ± 1.82 | 26.66 ± 2.04 | 0.09 ± 0.03 | 0.07 ± 0.01 | 0.14 ± 0.06 | 0.02 ± 0.01 | 0.32 ± 0.06 |
| Zicaitai | 0.46 ± 0.53 | 2.00 ± 2.00 | 2.04 ± 1.33 | nd | 4.50 ± 2.59 | 0.21 ± 0.19 | 0.12 ± 0.10 | 0.38 ± 0.54 | 0.12 ± 0.07 | 0.83 ± 0.74 |
PRO, progoitrin; NAP, gluconapin; GBN, glucobrassicanapin; GRA, glucoraphanin; GBC, glucobrassicin; 4ME, 4–methoxyglucobrassicin; NEO, neoglucobrassicin; 4OH, 4–hydroxyglucobrassicin. GSLs, glucosinolates. nd, not detected. Each value is the mean ± standard deviation.
Figure 1Schematic representation of the sequence variations of BrAOP2.1, BrAOP2.2, and BrAOP2.3 genes from “R-O-18” compared with “Chiifu-401/42.” Gray boxes represent exons, while lines denote introns. Short vertical lines show the non-synonymous SNP variations, and solid triangles and empty triangles indicate insertion and deletion variations, respectively. The SNP C/T at exon 2 (position + 499) of BrAOP2.2 causes a premature termination codon mutation named braop2.2, and a 209-bp insertion in exon 2 (position + 788) of BrAOP2.3 results in a frame shift and generates a premature stop product named braop2.3.
Figure 2HPLC analyses of enzymatic activity of three BrAOP2s of R-O-18 in vitro. Std1 and Std 2 indicate desulfatedgluconapin (NAP) standard and desulfated glucoraphanin (GRA) standard, respectively. Conversion of GRA to NAP was catalyzed by BrAOP2.1, but not by BrAOP2.2 or BrAOP2.3 protein. H2O shows as the negative control.
Figure 3Graphical genotype of the selected BC1 and BC2plants. The green region represents segments from the recurrent parent “L58,” the blue region represents segments from donor parent “R-O-18,” and the dark red region represents heterozygous segments.
Figure 4Glucoraphanin concentrations (A) and gluconapin concentration (B) in leaves of parental lines, F1 line and advanced backcross progenies. Data are shown as mean ± SD obtained from at least two biological replicates. Different letters indicate significant difference between genotypes (Tukey, P < 0.05).